Advertisement
Screener

Decibel Therapeutics, Inc. Operating Margin

Decibel Therapeutics, Inc. Operating Margin

  • Operating margin · 12 months: Value (m); Formula and calculation Operating income / revenue. Period ending 2023-06-30..

Operating margin

Overview →

Financial period ending 2023-06-30; current quote (m). Amounts retain their stated periods and units.

MetricValueFormula and calculation
Operating margin · 12 months(m)Operating income / revenue. Period ending 2023-06-30.

Calculation unavailable: missing inputs remain (m).

Calculation inputs

InputAmount with unitRaw financial data
Operating income-66.00M USDOperating Income (Loss)
Revenue(m)
Cost of products and services(m)
Research and development42.38M USDResearch and Development Expense
Selling, general and administration(m)

Calculated history

Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.

Period endingOperating income (USD)Revenue (USD)Cost of products and services (USD)Research and development (USD)Selling, general and administration (USD)Operating margin
2023-06-30$-66.00M(m)(m)$42.38M(m)(m)
2023-03-31$-64.06M(m)(m)$40.80M(m)(m)
2022-12-31$-63.96M(m)(m)$40.33M(m)(m)
2022-09-30(m)(m)(m)(m)(m)(m)
2022-06-30$-58.72M(m)(m)$35.71M(m)(m)
2022-03-31$-53.35M(m)(m)$31.29M(m)(m)
2021-12-31$-50.23M(m)(m)$29.85M(m)(m)
2021-09-30$-50.34M(m)(m)$29.76M(m)(m)
2021-06-30$-42.72M(m)(m)$25.43M(m)(m)
2021-03-31$-38.85M(m)(m)$23.91M(m)(m)
2020-12-31$-39.56M(m)(m)$25.32M(m)(m)
2020-09-30(m)(m)(m)(m)(m)(m)
2020-06-30(m)(m)(m)(m)(m)(m)
2020-03-31(m)(m)(m)(m)(m)(m)

(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.